Abstract
The use of mesenchymal stem cells (MSCs) for therapeutic applications has attracted great attention because MSCs home to and engraft to injured tissues after in vivo administration. The expression of osteopontin (OPN) is elevated in response to injury and inflammation, and its role on rat bone marrow-derived mesenchymal stem cells (rMSCs)-directed migration has been elucidated. However, the signaling pathways through the activation of which OPN promotes rMSCs migration and the involvement of cell mechanics during OPN-mediating rMSCs migration have not been well studied. In this study, we found that OPN activated focal adhesion kinase (FAK) and extracellular signal-regulated kinase (ERK) signaling pathways by the ligation of integrin β1 in rMSCs. Inhibitors of FAK and ERK pathways inhibited OPN-induced rMSCs migration, indicating the possible involvement of FAK and ERK activation in OPN-induced migration in rMSCs. In addition, atomic force microscopy analysis showed that OPN reduced cell stiffness in rMSCs via integrin β1, FAK, and ERK pathways, suggesting that the promotion of rMSCs migration might partially be contributing to the decrease in cell stiffness stimulated by OPN. To further examine the role of OPN on cell motility and stiffness, actin cytoskeleton of rMSCs was observed. The reduced well-defined F-actin filaments and the promoted formation of pseudopodia in rMSCs induced by OPN explained the reduction in cell stiffness and the increase in cell migration. The current study data have shown for the first time that OPN binding to integrin β1 promotes rMSCs migration through the activation of FAK and ERK pathways, which may be attributed to the change in cell stiffness caused by the reduction in the amount of organized actin cytoskeleton.
Similar content being viewed by others
References
Lubis, A. M., & Lubis, V. K. (2012). Adult bone marrow stem cells in cartilage therapy. Acta Medica Indonesiana, 44, 62–68.
Hong, H. S., Kim, Y. H., & Son, Y. (2012). Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing. Archives of Pharmacal Research, 35, 201–211.
Salem, H. K., & Thiemermann, C. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 28, 585–596.
Wang, K. X., & Denhardt, D. T. (2008). Osteopontin: role in immune regulation and stress responses. Cytokine & Growth Factor Reviews, 19, 333–345.
Koh, A., et al. (2007). Role of osteopontin in neutrophil function. Immunology, 122, 466–475.
Zou, C., Song, G., Luo, Q., Yuan, L., & Yang, L. (2011). Mesenchymal stem cells require integrin beta1 for directed migration induced by osteopontin in vitro. In Vitro Cellular and Developmental Biology Animal, 47, 241–250.
Saleem, S., et al. (2009). beta1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival. Journal of Pathology, 219, 182–192.
Cox, B. D., Natarajan, M., Stettner, M. R., & Gladson, C. L. (2006). New concepts regarding focal promotion of cell migration adhesion kinase and proliferation. Journal of Cellular Biochemistry, 99, 36–52.
Weiner, T. M., Liu, E. T., Craven, R. J., & Cance, W. G. (1993). Expression of focal adhesion kinase gene and invasive cancer. Lancet, 342, 1024–1025.
Gilmore, A. P., & Romer, L. H. (1996). Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Molecular Biology of the Cell, 7, 1209–1224.
Ilic, D., et al. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature, 377, 539–544.
Li, J. J., Han, M., Wen, J. K., & Li, A. Y. (2007). Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation. Biochemical and Biophysical Research Communications, 356, 13–19.
Ramos, J. W. (2008). The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. International Journal of Biochemistry & Cell Biology, 40, 2707–2719.
Howe, A. K., Aplin, A. E., & Juliano, R. L. (2002). Anchorage-dependent ERK signaling–mechanisms and consequences. Current Opinion in Genetics & Development, 12, 30–35.
Huang, C., Jacobson, K., & Schaller, M. D. (2004). MAP kinases and cell migration. Journal of Cell Science, 117, 4619–4628.
Krueger, J. S., Keshamouni, V. G., Atanaskova, N., & Reddy, K. B. (2001). Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene, 20, 4209–4218.
Kavurma, M. M., & Khachigian, L. M. (2003). ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. Journal of Cellular Biochemistry, 89, 289–300.
Shi, Y., et al. (2012). Neural cell adhesion molecule modulates mesenchymal stromal cell migration via activation of MAPK/ERK signaling. Experimental Cell Research, 318, 2257–2267.
Tang, J. M., et al. (2012). Acetylcholine induces mesenchymal stem cell migration via Ca2+/PKC/ERK1/2 signal pathway. Journal of Cellular Biochemistry, 113, 2704–2713.
Lautenschlager, F., et al. (2009). The regulatory role of cell mechanics for migration of differentiating myeloid cells. Proceedings of the National Academy of Sciences of the United States of America, 106, 15696–15701.
Cross, S. E., Jin, Y. S., Rao, J., & Gimzewski, J. K. (2007). Nanomechanical analysis of cells from cancer patients. Nature Nanotechnology, 2, 780–783.
Huang, H., Asimaki, A., Lo, D., McKenna, W., & Saffitz, J. (2008). Disparate effects of different mutations in plakoglobin on cell mechanical behavior. Cell Motility and the Cytoskeleton, 65, 964–978.
Luo, M., & Guan, J. L. (2010). Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis. Cancer Letters, 289, 127–139.
Miyazaki, K., et al. (2008). Corneal wound healing in an osteopontin-deficient mouse. Investigative Ophthalmology & Visual Science, 49, 1367–1375.
Robertson, B. W., Bonsal, L., & Chellaiah, M. A. (2010). Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells. Molecular Cancer, 9, 260.
Dai, J., et al. (2009). Osteopontin induces angiogenesis through activation of PI3 K/AKT and ERK1/2 in endothelial cells. Oncogene, 28, 3412–3422.
Brakebusch, C., & Fassler, R. (2005). Beta 1 integrin function in vivo: adhesion, migration and more. Cancer metastasis reviews, 24, 403–411.
Fong, Y. C., et al. (2009). Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells. Lung cancer, 64, 13–21.
Guck, J., Lautenschlager, F., Paschke, S., & Beil, M. (2010). Critical review: cellular mechanobiology and amoeboid migration. Integrative Biology, 2, 575–583.
Li, Q. S., Lee, G. Y., Ong, C. N., & Lim, C. T. (2008). AFM indentation study of breast cancer cells. Biochemical and Biophysical Research Communications, 374, 609–613.
Hampton, T. (2008). Lessening of cell stiffness might serve as new biomarker for malignancy. The Journal of the American Medical Association, 299, 276.
Rotsch, C., & Radmacher, M. (2000). Drug-induced changes of cytoskeletal structure and mechanics in fibroblasts: an atomic force microscopy study. Biophysical Journal, 78, 520–535.
Acknowledgments
This study was supported by grants from the Natural National Science Foundation of China (nos. 30770530, 11032012, 11102240 and 11272365), the Fundamental Research Funds for the Central University of China (no. CDJXS11232243), and the Natural Science Foundation Project of CQ CSTC (2010bb5236).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zou, C., Luo, Q., Qin, J. et al. Osteopontin Promotes Mesenchymal Stem Cell Migration and Lessens Cell Stiffness via Integrin β1, FAK, and ERK Pathways. Cell Biochem Biophys 65, 455–462 (2013). https://doi.org/10.1007/s12013-012-9449-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-012-9449-8